This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2007 Jun;12(3):70.

doi: 10.1136/ebm.12.3.70.

Continuing alendronate for an additional 5 years maintained bone mineral density in postmenopausal women

Affiliations

PMID: 17537878
DOI: 10.1136/ebm.12.3.70

Comment

Continuing alendronate for an additional 5 years maintained bone mineral density in postmenopausal women

Cory Baillie. Evid Based Med. 2007 Jun.

. 2007 Jun;12(3):70.

doi: 10.1136/ebm.12.3.70.

Author

Affiliation

¹ Manitoba Clinic, Winnipeg, Manitoba, Canada.

PMID: 17537878
DOI: 10.1136/ebm.12.3.70

No abstract available

PubMed Disclaimer

Comment on

Effects of continuing or stopping alendronate after 5 years of treatment: the Fracture Intervention Trial Long-term Extension (FLEX): a randomized trial.
Black DM, Schwartz AV, Ensrud KE, Cauley JA, Levis S, Quandt SA, Satterfield S, Wallace RB, Bauer DC, Palermo L, Wehren LE, Lombardi A, Santora AC, Cummings SR; FLEX Research Group. Black DM, et al. JAMA. 2006 Dec 27;296(24):2927-38. doi: 10.1001/jama.296.24.2927. JAMA. 2006. PMID: 17190893 Clinical Trial.

Publication types

Actions

LinkOut - more resources

Full Text Sources
- HighWire
- Ovid Technologies, Inc.